- On 18 September Escher published a report on how learning from regulatory practice can help improve the EU marketing authorisation system.
- A regulatory science perspective on adaptive approaches to marketing authorization: Towards appropriate levels of evidence
- Did the U.S. eclipse European pharmaceutical research productivity? An analysis of major reports as searchlights in the fog
Share this page…